Italy · Research startup

Canax

Canax is an Italian company based in Milan that specializes in producing and selling high-quality CBD (cannabidiol) products and cannabis sativa-derived ingredients.

Funding reportedLast round: Debt financing

ResearchMilan, Italy

About Canax

Canax is an Italian company based in Milan that specializes in producing and selling high-quality CBD (cannabidiol) products and cannabis sativa-derived ingredients.

Their offerings cater to various sectors, including medical, cosmeceutical, nutraceutical, and veterinary applications. With over 25 years of experience, Canax emphasizes strict quality control throughout its production process, from plant cultivation to final product formulation. The company manufactures a wide range of CBD-based products, including CBD isolates, oils, water-soluble formulations, tinctures, capsules, and both edible and topical products. Canax also provides white-label services for custom production and formulation of CBD oils and natural cosmetics. Utilizing supercritical CO2 extraction technology, Canax ensures high product quality and environmental sustainability in its operations. The company serves as a wholesale supplier and strategic partner for ingredient and product distribution, collaborating with industry leaders in extraction services.

What company datasets say Canax raised

Funding, as reported

Reported in all2.5Min the source's currency
Rounds2
Last roundDebt financing
Last round size1.4M
Last round dateMar 2022

The company, in detail

What they build

Known for

health carecannabisconsumersbiotechnology researchfarmaceuticaextraction technologybiomass recyclingcbdwater-soluble cbdinformation technology & servicescertifications haccpcbd isolateco2 supercriticaaestheticclinical research cbdextraction

Built with from their website

Font AwesomeJ2EEjsDelivrBootstrap

Sector
Research
Industry code
NAICS 32541, SIC 2834
Region
Lombardy
Full record
Every detail in the company directory

Research in Italy

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Canax in front of investors. Or tell us what we have wrong.